cirsimaritin has been researched along with oleanolic acid in 3 studies
| Studies (cirsimaritin) | Trials (cirsimaritin) | Recent Studies (post-2010) (cirsimaritin) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
|---|---|---|---|---|---|
| 49 | 0 | 21 | 4,169 | 31 | 2,404 |
| Protein | Taxonomy | cirsimaritin (IC50) | oleanolic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
| Phospholipase A2 | Homo sapiens (human) | 3 | |
| DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
| Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
| Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
| Tissue factor | Homo sapiens (human) | 0.005 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
| Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
| Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
| Transcription factor p65 | Homo sapiens (human) | 2.4 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
| Protease | Human immunodeficiency virus 1 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Hayes, T; Ross, SA; Srivedavyasasri, R | 1 |
| Bilia, AR; Hadjipavlou-Litina, D; Karioti, A; Stefanis, I | 1 |
3 other study(ies) available for cirsimaritin and oleanolic acid
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Phytochemical and biological evaluation of Salvia apiana.
Topics: Abietanes; California; Drug Evaluation, Preclinical; Flavones; Magnetic Resonance Spectroscopy; Mexico; Oleanolic Acid; Phytochemicals; Plant Extracts; Plant Leaves; Plants, Medicinal; Receptor, Cannabinoid, CB1; Receptors, Opioid; Salvia; Triterpenes; Ursolic Acid | 2017 |
LC-MS- and NMR-Guided Isolation of Monoterpene Dimers from Cultivated Thymus vulgaris Varico 3 Hybrid and Their Antityrosinase Activity.
Topics: Flavones; Gas Chromatography-Mass Spectrometry; Magnetic Resonance Spectroscopy; Monophenol Monooxygenase; Monoterpenes; Oleanolic Acid; Plant Extracts; Thymol; Thymus Plant; Triterpenes; Ursolic Acid | 2019 |